They Needed Preservative-Free Eye Drops. Allergan Sold Them a Lie.

Allergan Lied About “Preservative-Free” Eye Drops for Years
EvilCorporations.com  |  Corporate Accountability Reporting
Allergan USA  ·  Consumer Fraud  ·  2025–2026

Allergan Labeled Eye Drops “Preservative-Free” While Knowingly Including a Chemical Preservative

Consumers paid premium prices for a false promise. Thousands were deceived nationwide, buying a product that contained the very ingredient they were trying to avoid.

🏭 Pharmaceutical / Consumer Health
📋 Class Action
📅 Filed January 28, 2026
●  HIGH SEVERITY
TL;DR

Allergan USA sold its Refresh Tears PF eye drops under a bold “Preservative-Free” label, a claim printed prominently on the packaging and used to justify a premium price. The problem: the product contains boric acid, a substance that acts as a preservative by halting bacterial growth. Allergan’s own chemists formulated the product. The company knew exactly what was in it.

Thousands of consumers, including people with sensitive eyes who specifically sought preservative-free options, were deceived. They paid more for a product they believed was formulated differently. They trusted the label. Allergan exploited that trust to extract more money from them.

This is not a technicality. This is a company that looked at its customers and decided they were not educated enough to notice the lie. That conduct is unacceptable, and the people harmed deserve accountability.

1,000+
Estimated class members (thousands, per complaint)
5 yrs
Class period covered by the lawsuit
4
Legal counts filed: fraud, deceptive trade, unjust enrichment
2
States with sub-classes: Illinois and Nevada

⚠️ The Allegations: A Breakdown

⚠️
Core Allegations
What they did  ·  6 points
01 Allergan marketed, sold, and distributed Refresh Tears PF eye drops across the United States with prominent “Preservative-Free” labeling. high
02 The products contain boric acid, a substance documented in peer-reviewed science as a preservative due to its bacteriostatic properties in biological mediums and its established use in multidose eyedrops. high
03 Allergan employed professional chemists who formulated the products. The company knew, or should have known, that boric acid functions as a preservative. high
04 The complaint alleges that Allergan chose to continue labeling the product as “preservative free” because it did not believe its customers were educated enough to know the difference. high
05 Consumers who purchased the product did so specifically because of the “preservative-free” claim and had no way to know the label was false without Allergan disclosing it directly. high
06 Allergan’s false labeling allowed it to sell the product at a higher price and in greater volume than it could have achieved with accurate labeling, profiting from the deception directly. high
💰
Profit Over People
Revenue prioritized over honesty  ·  5 points
01 Allergan used the “preservative-free” label to increase consumer demand by incentivizing purchases based on a perceived product feature that did not actually exist. high
02 Plaintiffs and class members paid a price premium for a premium product feature. They received a standard product containing preservatives instead. high
03 Allergan extracted additional funds from consumers who would not have purchased the product, or would not have paid as much, had they known the true formulation. high
04 The false labeling harmed honest competitors by steering consumers away from truthfully-labeled products toward Allergan’s falsely-advertised one. med
05 Allergan retained unjust revenue from these sales and, under the complaint’s unjust enrichment count, consumers seek full restitution of money paid. high
📉
Economic Fallout
Financial harm to consumers  ·  4 points
01 Plaintiffs lost money directly: they paid for a product benefit that was false. They were denied the value of the bargain they thought they made. high
02 Consumers wasted time purchasing, using, and potentially returning or replacing a product they would not have chosen had the label been accurate. med
03 The class is estimated to include thousands of purchasers across the United States within the five-year class period. med
04 Damages sought include actual damages, punitive damages, injunctive relief, restitution, and attorney’s fees and costs. med
⚖️
Corporate Accountability Failures
How Allergan avoided responsibility  ·  4 points
01 Allergan never proactively notified consumers that their “preservative-free” products contained a preservative, allowing the deception to continue across the entire five-year class period. high
02 The complaint alleges Allergan intentionally exploited the information gap between a corporation with employed chemists and consumers who cannot be expected to know that boric acid is a preservative. high
03 No individual executives are named with personal liability in this filing. The corporation alone faces consequences, a pattern that insulates the decision-makers who approved the false label. med
04 Without a class action, thousands of individual consumers would have no practical path to legal redress, as their individual claims are too small to litigate alone, a structural advantage the complaint explicitly addresses. med
🗣️
The Language of Legitimacy
How a label neutralizes harm  ·  3 points
01 The “PF” designation (Preservative-Free) is a recognized health-oriented marketing claim that carries specific meaning for consumers with eye conditions, allergies, or sensitivities to preservatives in ocular products. high
02 Allergan used a scientifically credible health claim as a marketing tool while the product’s formulation contradicted that claim. The label’s authority made the deception harder to detect. high
03 Consumers could not reasonably have been expected to know that boric acid, an ingredient listed separately on the product, also functions as a preservative. That knowledge gap is precisely what Allergan reportedly exploited. med

🕐 Timeline of Events

Ongoing (5 yrs prior)
Allergan manufactures, advertises, and sells Refresh Tears PF products nationwide with “Preservative-Free” labeling. Boric acid is included in the formulation throughout this period.
June 27, 2025
Plaintiff Raevin Dotson (Las Vegas, NV) purchases Refresh Tears PF from Amazon.com, relying on the “preservative-free” label to make her purchase decision.
Nov 6, 2025
Plaintiff John Daly (Chicago, IL) purchases Refresh Tears PF from a Walgreens location in Chicago, also relying on the “preservative-free” label.
Jan 28, 2026
Class action complaint filed in the Circuit Court of Cook County, Illinois, Chancery Division (Case No. 2026CH00826). Plaintiffs seek damages and injunctive relief on behalf of all US purchasers within the class period.
Mar 30, 2026
Hearing date scheduled before Judge Michael Tully Mullen in Cook County, Court Room 2510.

💬 Direct Quotes from the Legal Record

QUOTE 1 Allergan’s deliberate choice to deceive Core Allegations
“Defendant did know that Products contained a preservative but chose to label the Products as ‘preservative free’ because it did not believe its customers were well educated enough to know the difference.”
💡 This is the most damning line in the complaint. It alleges that Allergan’s choice was not a mistake or an oversight but a calculated decision to exploit consumer ignorance for profit.
QUOTE 2 Knowing deception by trained chemists Core Allegations
“Defendant employs professional chemists to create the chemical formulas of Defendant’s Products. Therefore, Defendant through its employees knew or should have known that boric acid is a preservative.”
💡 This directly counters any claim of ignorance. The company had the in-house expertise to know its own product was mislabeled.
QUOTE 3 Consumers paid a premium for a false feature Profit Over People
“Plaintiffs and the Class paid a price premium for a premium Product, but instead received a non-premium Product with preservatives.”
💡 This quantifies the consumer harm in plain terms: people paid more for something they did not receive.
QUOTE 4 False label manipulated purchasing decisions Core Allegations
“Defendant coerced consumers to base their purchasing decision in material part on false claims, thereby fraudulently, deceptively, and unfairly increasing consumer demand for the product.”
💡 The complaint frames this not as passive mislabeling but as active manipulation of consumer decision-making through false information.
QUOTE 5 Consumers could not have discovered the deception Core Allegations
“Due to Defendant’s intentional, deceitful practice of falsely labeling the Products as ‘preservative free’, Plaintiff could not have known that the Product contained a preservative.”
💡 This establishes that the deception was structurally impossible to detect, consumers had to trust the label. Allergan weaponized that trust.
QUOTE 6 Allergan harmed honest competitors too Profit Over People
“Harmed competitors by luring would-be consumers of competitive products away from law-abiding products that were not so falsely advertised.”
💡 The deception did not only harm buyers. It distorted the market and punished companies that chose to label their products accurately.

💬 Commentary

Is boric acid actually a preservative?
Yes. Boric acid has bacteriostatic properties, meaning it inhibits bacterial growth. According to published pharmaceutical science cited in the complaint (Journal of Pharmaceutical Sciences, 2020), boric acid works as a preservative due to its acidic properties and its nonselective action in biological mediums. It is widely used as a preservative in multidose eyedrops. Calling a product containing boric acid “preservative-free” is, by the science, a false statement.
How serious is this lawsuit?
This is a substantive class action filed in Cook County, Illinois under four separate legal counts: violations of the Nevada Deceptive Trade Practices Act, the Illinois Consumer Fraud and Deceptive Business Practices Act, common law fraud, and unjust enrichment. The plaintiffs seek actual damages, punitive damages, injunctive relief, and attorney’s fees. The multi-count structure and the explicit allegation of intentional deception (that Allergan knew and chose to proceed anyway) make this a meaningfully serious claim. Whether it results in a judgment or settlement remains to be seen at trial.
Why does this matter beyond the product itself?
People with eye conditions such as dry eye syndrome, contact lens sensitivity, or post-surgical care needs specifically seek preservative-free formulations because preservatives can irritate sensitive ocular tissue or cause adverse reactions with long-term use. When a company slaps “Preservative-Free” on a product that contains a preservative, it is not just misleading marketing. It could cause real harm to the most vulnerable buyers: those who needed the real thing most. That is the human cost behind the consumer fraud count.
Couldn’t consumers have just read the ingredient label?
This is the defense Allergan may attempt to raise, and the complaint directly addresses it. The average consumer is not a pharmaceutical chemist. They cannot be expected to know that boric acid, an ingredient listed on a label, is also functioning as a preservative. The “Preservative-Free” claim is on the front of the package, in large type, as a primary selling point. Consumers have a legally protected right to rely on a company’s affirmative representations about its own product. The burden is on Allergan to tell the truth, not on consumers to reverse-engineer the chemistry of every product they buy.
This is part of a broader pattern of corporate deception in consumer health products.
Allergan’s alleged conduct fits a documented pattern in the consumer health and pharmaceutical industries: companies identify a health-oriented claim that commands premium pricing, apply it to products that do not fully meet that claim, and profit from the gap between what consumers believe they are buying and what they actually receive. “Natural,” “organic,” “gluten-free,” “BPA-free,” and now “preservative-free”: these terms are regularly litigated because corporations have financial incentives to stretch or falsify them. The harm is real, the pattern is real, and holding Allergan accountable matters for every consumer who buys health products based on label claims they cannot independently verify.
What can I do to prevent this from happening again?
Several concrete actions matter. If you purchased Refresh Tears PF products, monitor ClassAction.org and the Cook County court docket (Case No. 2026CH00826) for class certification. Joining the certified class, if eligible, is free and requires no individual legal action. Beyond this case: report deceptive product labeling to the FTC (reportfraud.ftc.gov) and your state attorney general. Support and contact your representatives about stronger labeling enforcement at the FDA. Share this case publicly: Allergan’s business model depends on consumers not knowing or not caring. Awareness is accountability. The more people know, the more expensive this conduct becomes for corporations that choose to practice it.

💡 Explore Corporate Misconduct by Category

Corporations harm people every day — from wage theft to pollution. Learn more by exploring key areas of injustice.

Aleeia
Aleeia

I'm Aleeia, the creator of this website.

I have 6+ years of experience as an independent researcher covering corporate misconduct, sourced from legal documents, regulatory filings, and professional legal databases.

My background includes a Supply Chain Management degree from Michigan State University's Eli Broad College of Business, and years working inside the industries I now cover.

Every post on this site was either written or personally reviewed and edited by me before publication.

Learn more about my research standards and editorial process by visiting my About page

Articles: 1734
🏳️‍⚧️ trans rights are human rights 🏳️‍⚧️
Theme